CCN2 and Hepatic fibrosis: CTGF promoted phenotypic changes of HSCs into MYFs, whereas inhibition of CTGF promoter methylation enhanced this process, suggesting that CTGF group promoter methylation may negatively regulate hepatic fibrosis (158).